Product Information

TRAMADOL HCL 50 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0257 per EA under NDC 16571071610. Its NADAC has been published 213 times since Oct 26, 2022.

FDA first approved this application on Mar 31, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRAMADOL HCL 50 MG TABLET

Tramadol Hydrochloride
$0.0257per EA
DEA Schedule CIV

Strength

50 mg/1

NDC

16571071610

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TRAMADOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203494

FDA Approved

3/31/2014

TE Code

AB

On Market Since

9/23/2020

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for TRAMADOL HCL 50 MG TABLET has been published 213 times since Oct 26, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0257 per EA
All-time high$0.0355 (Apr 10, 2024)
All-time low$0.0219 (Nov 20, 2024)
52-week high$0.0260
52-week low$0.0235
Median price$0.0254
Average price$0.0265
Largest weekly change-31.3% (Nov 20, 2024)
Weeks tracked213
Tracking sinceOct 26, 2022

Price History

1W

-1.3%

1M

+3.6%

3M

+4.7%

6M

+8.6%

1Y

+5.5%

3Y

-15.7%

5Y

N/A

All

-1.9%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRAMADOL HCL 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TRAMADOL HCL 50 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0257 per EA (NDC 16571071610), effective Nov 18, 2026.

How has the price of TRAMADOL HCL 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for TRAMADOL HCL 50 MG TABLET has held within roughly two percent of its current level. It has been tracked across 213 weekly CMS publications since Oct 26, 2022.

What are the highest and lowest recorded NADAC prices for TRAMADOL HCL 50 MG TABLET?

Since Oct 26, 2022, the NADAC for TRAMADOL HCL 50 MG TABLET has ranged from a low of $0.0219 (Nov 20, 2024) to a high of $0.0355 (Apr 10, 2024), with a median of $0.0254 per EA.

Are there cheaper alternatives to TRAMADOL HCL 50 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRAMADOL HCL 50 MG TABLET, is $0.0239 per EA — about 7% below TRAMADOL HCL 50 MG TABLET.

Who manufactures TRAMADOL HCL 50 MG TABLET?

TRAMADOL HCL 50 MG TABLET (NDC 16571071610) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.